Please assess the completion status of the following clinical trial:

Trial Title: Colchicine and CRP in Atrial Fibrillation and AF Ablation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Group 1: Persistent or chronic AF presenting for evaluation in cardiology offices. Diagnosis of AF will be made based on the 12 -lead surface ECG.~* Group 2: Paroxysmal AF scheduled to go AF ablation presenting to the electrophysiology laboratory for the procedure in sinus rhythm..~* Group 3:Chronic AF scheduled to go clinically indicated AF ablation, and presenting in the electrophysiology laboratory in atrial fibrillation .~Exclusion Criteria:~1. Abnormal liver function with elevated enzymes\> 1.5 times the normal.~2. Abnormal kidney function with glomerular filtration rate \< 50 ml/min~3. Increased levels of creatine kinase or known myopathy~4. Neutropenia~5. Known GI disorders~6. Women of childbearing age who have not had surgical sterilization and are not using oral contraceptives, or who's spouse has not had surgical sterilization will be excluded due to the length of the trial and the possibility that they could become pregnant after entry.~7. Pregnant and lactating women~8. Lactose intolerance~9. Known sensitivity, allergy, or contraindication to colchicine use

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Chronic atrial fibrillation, colchicine (Type: ACTIVE_COMPARATOR): Colchicine 0.6 mg PO BID. Subjects not undergoing ablation.
- Chronic atrial fibrillation, placebo (Type: PLACEBO_COMPARATOR): Matching placebo. Subjects not undergoing ablation.
- Pre-ablation, sinus rhythm, colchicine (Type: ACTIVE_COMPARATOR): Colchicine 0.6 mg PO BID. Subjects undergoing ablation.
- Pre-ablation, sinus rhythm, placebo (Type: PLACEBO_COMPARATOR): Matching placebo. Subjects undergoing ablation.
- Pre-ablation, AF, colchicine (Type: ACTIVE_COMPARATOR): Colchicine 0.6 mg PO BID. Subjects undergoing ablation.
- Pre-ablation, AF, placebo (Type: PLACEBO_COMPARATOR): Matching placebo. Subjects undergoing ablation.

Based on this trial design, predict the completion outcome and termination type (if applicable).